Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wearable device aims to diagnose dizziness causes automatically

NCT ID NCT05984901

Diagnosis Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a wearable device that tracks eye movements during dizzy spells to help doctors tell apart three common inner-ear conditions: Ménière's disease, vestibular migraine, and BPPV. Four adults wore the device for 30 days to capture data. The goal was to develop a computer algorithm that can automatically diagnose these conditions, potentially speeding up and improving care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

4 people

The number who actually took part.

Started

Apr 2022

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 and over 2. Must have relevant index medical condition: Ménière's Disease, Vestibular Migraine, posterior canal Benign Paroxysmal Positional Vertigo (see section 6.3.1.2 for specific criteria) 3. Experiencing episodes of true vertigo with at least 2 episodes within the preceding 4 weeks at time of consent 4. The duration and nature of the vertigo is of a duration and a nature supportive of the relevant index medical condition 5. Owns and able to use a telephone 6. Willing to provide informed consent 7. Willing to comply with the study protocol for using the CAVA device 8. Willing to complete all study materials 9. Adequate grasp of the English language or language used within an existing translated version of the informed consent form and patient information sheet and where hospital translators are available to provide support Exclusion Criteria: 1. Has an allergy to plasters and/or medical adhesives 2. Evidence of dermatitis, fragile skin, or any other condition that could be aggravated by the repeated application of skin surface adhesives 3. Pregnant or breastfeeding mothers 4. Bilateral or second side Ménière's Disease 5. Active bilateral or second side posterior canal Benign Paroxysmal Positional Vertigo 6. Currently enrolled on an intervention trial (not including questionnaire-based or observational trial) 7. Patients who meet diagnostic criteria for more than one eligible condition at time of recruitment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign paroxysmal positional vertigo (BPPV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

benign paroxysmal positional vertigo Meniere disease migraine with brainstem aura

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign paroxysmal positional vertigo (BPPV) Ménière's disease Vestibular migraine

Contacts and locations

Locations

  • Norfolk and Norwich University Hospitals Foundation Trust

    Norwich, Norfolk, NR4 7UY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.